📰 Lawrence Eichenfield News
Page 2 - Lawrence Eichenfield News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lawrence Eichenfield. Real-time updates on events, politics, business and more.
November 29, 2023
FDA has set a PDUFA target action date of July 07, 2024Atopic dermatitis affects approximately 16.5 million adults and 9.6 million children in the United StatessNDA supported by positive efficacy and...
October 23, 2023
Dr. Eichenfield used this interview segment to respond to the FDA’s recent decision not to approve dupilumab for chronic spontaneous urticaria.
October 22, 2023
Dr. Eichenfield spoke in this interview segment on the tips shared in his presentation at the Fall Clinical Dermatology conference in Las Vegas.
October 22, 2023
In this interview, Dr. Eichenfield shared his views on this week’s approval by the FDA of IDP-126 for patients 12 and older with acne.
October 21, 2023
Designed to treat the acne's inflammation, bacteria and follicular hyperkeratinization, IDP-126 has shown significant efficacy compared to standard-care options already on the market.
October 5, 2023
The La Jolla Light presents this continuing listing of online activities and local in-person events.
October 3, 2023
The La Jolla Light presents this continuing listing of online activities and local in-person events.
September 28, 2023
The La Jolla Light presents this continuing listing of online activities and local in-person events.
September 27, 2023
The La Jolla Light presents this continuing listing of online activities and local in-person events.
September 14, 2023
Both Leading Independent Proxy Advisory Firms Conclude Forte’s Poor Performance and Dilutive, Anti-Stockholder Actions Under Chairman and CEO Dr. Paul Wagner’s Leadership Indicate Boardroom...